n CME : Your SA Journal of CPD - Pharm info
|Article Title||Pharm info|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||CME : Your SA Journal of CPD|
|Publication Date||Aug 2004|
|Pages||477 - 479|
Extracted from text ... Should we consider the routine administration of ACE inhibitors such as perindopril in all people with coronary artery disease (CAD)? 'Yes, ' said Professor Willem Remme of the Sticares Cardiovascular Research Institute, Rhoon, the Netherlands, as he concluded his presentation on the EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) study to doctors around South Africa. The EUROPA study was designed to assess whether the long-term administration of perindopril, added to standard preventive therapy, would reduce cardiovascular events in a broad spectrum of patients with definite evidence of CAD, irrespective of their ..
Article metrics loading...